Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1980-2-15
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0003-4819
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
91
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
916-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:517895-Antiemetics,
pubmed-meshheading:517895-Drug Evaluation,
pubmed-meshheading:517895-Drug and Narcotic Control,
pubmed-meshheading:517895-Humans,
pubmed-meshheading:517895-National Institutes of Health (U.S.),
pubmed-meshheading:517895-Tetrahydrocannabinol,
pubmed-meshheading:517895-United States,
pubmed-meshheading:517895-United States Food and Drug Administration
|
pubmed:year |
1979
|
pubmed:articleTitle |
Tetrahydrocannabinol: from pot to prescription?
|
pubmed:publicationType |
Journal Article
|